Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
100%
Apolipoprotein M
100%
Adverse Outcomes
100%
Human Heart Failure
100%
Sphingosine-1-phosphate
71%
Hazard Ratio
57%
High-density Lipoprotein Particles
42%
Heart Failure with Preserved Ejection Fraction (HFpEF)
42%
Failure Studies
42%
High-density Lipoprotein Cholesterol (HDL-C)
28%
Inflammation
28%
Ventricular Assist Device
28%
Negative Association
28%
TOPCAT
28%
University of Washington
28%
Heart Transplantation
28%
Risk of Death
14%
Inflammatory Markers
14%
Mortality Hazard
14%
Therapeutic Target
14%
Receptor Activation
14%
Biological Pathways
14%
Coagulation System
14%
Cardiac Function
14%
Aldosterone Antagonists
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
14%
Cardioprotection
14%
Device Implantation
14%
Anti-inflammatory Effect
14%
Physical Interaction
14%
Liver X Receptor
14%
Canonical Pathway
14%
SOMAscan Assay
14%
Modified Aptamers
14%
Aptamer-based
14%
Retinoid X Receptor
14%
Strongly Correlated
14%
Apolipoprotein A-I (apoA-I)
14%
Biochemistry, Genetics and Molecular Biology
Sphingosine-1-Phosphate
100%
Apolipoprotein
100%
High-Density Lipoprotein
80%
Heart Ejection Fraction
40%
HDL-Cholesterol
20%
Enzyme
20%
Animal Model
20%
Heart Function
20%
Coagulation System
20%
Liquid Chromatography-Mass Spectrometry
20%
Aptamer
20%
Retinoid X Receptor
20%
Liver X Receptor
20%
Artificial Intelligence
20%
Aldosterone
20%
Anti-Inflammatory
20%
Biological Pathway
20%
Medicine and Dentistry
Adverse Outcome
100%
Congestive Heart Failure
100%
Apolipoprotein M
100%
Sphingosine 1 Phosphate
33%
Hazard Ratio
26%
High-Density Lipoprotein
26%
Heart Transplantation
13%
Ventricular Assist Device
13%
Heart Failure with Preserved Ejection Fraction
13%
Inflammation
13%
High Density Lipoprotein Cholesterol
6%
Anti-Inflammatory Drug
6%
Enzyme Linked Immunosorbent Assay
6%
Blood Clotting
6%
Heart Function
6%
Aldosterone Antagonist
6%
Liquid Chromatography-Mass Spectrometry
6%
Study Participant
6%
Aptamer
6%
Heart Failure with Reduced Ejection Fraction
6%
Liver X Receptor
6%
Retinoid X Receptor
6%
Artificial Intelligence
6%
Therapeutic Target
6%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Apolipoprotein M
100%
Adverse Outcome
100%
Sphingosine 1 Phosphate
33%
High Density Lipoprotein
26%
Inflammation
13%
Heart Failure with Preserved Ejection Fraction
13%
High Density Lipoprotein Cholesterol
6%
Enzyme-Linked Immunosorbent Assay
6%
Anti-Inflammatory Drug
6%
Aldosterone Antagonist
6%
Aptamer
6%
Heart Failure with Reduced Ejection Fraction
6%
Liver X Receptor
6%
Retinoid X Receptor
6%